Dr. Amenta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Joslin Place
President and CEO
Boston, MA 02215Phone+1 617-309-2420Fax+1 617-732-2487- Is this information wrong?
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Pathology-Anatomic and Clinical, 1980 - 1984
- Drexel University College of MedicineClass of 1980
Certifications & Licensure
- NJ State Medical License 1989 - 2025
- PA State Medical License 1982 - 2002
- American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.Bajpai, M.,Seril, D. N.,Van Gurp, J.,Geng, X.,Alvarez, J.,Minacapelli, C. D.,Gorin, S.,Das, K. K.,Poplin, E.,Cheng, J.,Amenta, P. S.,Das, K. M.> ;Dig. Dis. Sci.. 2018 Nov 28
- miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis.Minacapelli, C. D.,Bajpai, M.,Geng, X.,Van Gurp, J.,Poplin, E.,Amenta, P. S.,Brant, S. R.,Das, K. M.> ;Inflamm. Bowel Dis.. 2018 Sep 12
- 2 citationsGiant hyperplastic polyps of the gastric remnant simulating carcinomaSeth N. Glick, Steven K. Teplick, Peter S. Amenta> ;Gastrointestinal Radiology. 1990 Jan 1
- Join now to see all
Press Mentions
- Peter S. Amenta, MD, Ph.D., Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's WhoAugust 29th, 2018
- New Joslin Diabetes CEO Taking a Measured ApproachFebruary 3rd, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: